Tuesday 11 June 2019

Minimally Invasive Surgical Instruments to Promote Healthcare Resources


As per the report by Grand View Research, Inc., the Minimally Invasive Surgical Instruments Market was valued at USD 18.3 billion in 2017 and is projected to exhibit a healthy CAGR of 9.7% throughout the forthcoming period (2018-2025). Improved performance of minimally invasive surgeries as compared to traditional open surgeries is likely to propel the market growth in the forecast period. Furthermore, increasing chronic disorders, rise in number of surgeries as well as innovations in technology are the factors that are likely to drive the market in the near future.

In addition, surge in the aged populace and increasing number of surgeries associated with them such as orthopedic surgeries, cardiac surgeries, etc. will drive the market growth in the years to come. Also, benefits of minimally invasive surgeries over conventional surgeries, such as shorter hospital stay, low tissue damage, less scaring, and lesser pain is expected to drive the market growth. 

On the other hand, absence of proper reimbursement scenario, lack of trained surgeons in developing countries, and improper sterilization methods may hinder the market growth over the forecast period. 

In May 2017, Medtronic plc received the Food and Drug Administration (FDA) approval and introduced the Resolute Onyx Drug-Eluting Stent (DES). It supports the gold standard efficacy and safety of DES technique.  Subsequently, the company received approval from the USFDA for the launch of Core Valve Evolut PRO valve, designed for symptomatic patients who have gone through open heart surgeries.

The emerging trend in the minimally invasive surgical instruments is increasing demand for medical tourism and increase in number of surgical procedures performed in developing countries such as India, China, Brazil, South Korea, Thailand, Mexico, and Malaysia.
North America became a dominant segment in the region in 2017 owing to the rising geriatric population and high rate of unintentional injuries.

Stryker; Medtronic; Abbott; Smith & Nephew; NuVasive, Inc.; Zimmer Biomet; Intuitive Surgical, Inc; and CONMED are some of the leading players in the minimally invasive surgical instruments market
Access a Press Release on Minimally Invasive Surgical Instruments Market @ https://www.grandviewresearch.com/press-release/global-minimally-invasive-surgical-instruments-market

No comments:

Post a Comment

Insulin Delivery Devices Market To Reach $28.06 Billion By 2030

  The global  Insulin Delivery Devices Market  size was estimated at USD 28.06 billion in 2030 and is expected to grow at a CAGR of 7.89% fr...